Emerging therapies for the treatment and prevention of otitis media

Expert Opinion on Emerging Drugs
Avner AliphasKenneth M Grundfast

Abstract

Otitis media is one of the most common disorders occurring in children, and there is growing concern that bacteria are quickly becoming resistant to antimicrobials. As a result, global antibiotic treatment is no longer the standard of care and treatment of otitis media has changed dramatically in the last decade. In addition to new antimicrobials currently in development, the effects of the pneumococcal conjugate vaccine are just beginning to be understood. Furthermore, new surgical techniques are for the first time being tested as alternatives for tympanostomy tubes for recurrent acute otitis media. This review discusses current and emerging otitis media therapeutics, with particular attention to acute otitis media. Topics include antimicrobial use, antimicrobial resistance, effects of vaccination and new surgical techniques.

References

Jun 1, 1976·Archives of Otolaryngology·V K Misurya, P K Shrivastava
Apr 1, 1992·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·R M Rosenfeld, J C Post
Sep 1, 1991·Archives of Otolaryngology--head & Neck Surgery·R M RosenfeldC D Bluestone
Jan 1, 1989·The Pediatric Infectious Disease Journal·S E Stool, M J Field
Aug 1, 1989·The Journal of Infectious Diseases·J Renneberg, M Walder
Aug 1, 1983·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·J L ParkinJ C Stringham
Apr 1, 1996·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·G A Gates
Jun 1, 1997·Archives of Pediatrics & Adolescent Medicine·D MatsuiM J Rieder
Feb 5, 1998·JAMA : the Journal of the American Medical Association·M G RaynerG D Ehrlich
Jun 12, 1998·JAMA : the Journal of the American Medical Association·M E Pichichero
Dec 16, 1998·The Pediatric Infectious Disease Journal·C D Bluestone
Apr 6, 1999·International Journal of Pediatric Otorhinolaryngology·E L GoldblattM Seidlin
Dec 23, 1999·The Pediatric Infectious Disease Journal·J L Blumer
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W P HausdorffG R Siber
Apr 5, 2000·The Journal of Antimicrobial Chemotherapy·J Fung-TomcD Bonner
Feb 13, 2001·Vaccine·D W TeeleUNKNOWN Greater Boston Otitis Media Study Group
Feb 13, 2001·Vaccine·M UhariT Kontiokari
Feb 15, 2001·The New England Journal of Medicine·J EskolaUNKNOWN Finnish Otitis Media Study Group
Feb 24, 2001·Expert Opinion on Investigational Drugs·N S Ryder
Mar 16, 2001·International Journal of Pediatric Otorhinolaryngology·J I De DiegoJ Gavilan
Apr 17, 2001·The Pediatric Infectious Disease Journal·A LeibermanR Dagan
Jun 22, 2001·The Journal of Antimicrobial Chemotherapy·C Slater-RadostiD D Jaworski
Sep 22, 2001·The Journal of Antimicrobial Chemotherapy·S Douthwaite, W S Champney
Jan 22, 2002·The Laryngoscope·J C Post
Apr 3, 2002·JAMA : the Journal of the American Medical Association·Garth D EhrlichJ Christopher Post
Jun 19, 2002·JAMA : the Journal of the American Medical Association·Linda F McCaigJames M Hughes
Jun 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paola MarchisioNicola Principi
Aug 13, 2002·The Laryngoscope·David H Darrow, Christopher Siemens
Jan 25, 2003·The Pediatric Infectious Disease Journal·Bruce FiremanPaula Ray
Apr 3, 2003·The Laryngoscope·Dennis S PoeOskar Kujawski
Apr 8, 2003·Current Topics in Medicinal Chemistry·Toshifumi AsakaHiroyuki Sugiyama
Jun 7, 2003·International Journal of Pediatric Otorhinolaryngology·Hiroko MonobeJun Yano
Jun 18, 2003·Pediatric Clinics of North America·Stephen M Weber, Kenneth M Grundfast
Sep 25, 2003·JAMA : the Journal of the American Medical Association·Alejandro HobermanJill D Kerr
Oct 22, 2003·The Pediatric Infectious Disease Journal·Jerome O Klein
Nov 5, 2003·International Journal of Pediatric Otorhinolaryngology·M StraetemansT Kilpi

❮ Previous
Next ❯

Citations

May 25, 2011·Pediatrics·Carole LannonAnthony Goudie
Mar 26, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Laura Freire-MoranUNKNOWN ECDC-EMA Working Group
Apr 23, 2010·International Journal of Pediatric Otorhinolaryngology·Gerhard Grevers, UNKNOWN First International Roundtable ENT Meeting Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved